Stay updated with breaking news from Cath Mummery. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Any treatment for Alzheimer’s is to be welcomed — especially if it’s an expensive drug already in use for another condition. Any treatment for Alzheimer’s is to be welcomed, especially if it’s an expensive drug already in use.
The company Eli Lilly has reported its drug - donanemab - slows the pace of Alzheimer's by about a third.
A new drug can reduce symptoms of Alzheimers disease by 35 per cent.
A new Alzheimer's drug, 'donanemab', was found to clear amyloid plaques from the brains, and slow cognitive decline by about a third.
Top doctors today warned that the NHS is not ready to dish out the medication, made by US-based pharmaceutical giant Eli Lilly, and needs to 'gear up' now in preparation to do so.